{
    "organizations": [],
    "uuid": "4d328756a35a0c3b3915ba43031e90feeceaaffd",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-abiomed-receives-approval-for-expa/brief-abiomed-receives-approval-for-expanded-fda-indication-for-high-risk-pci-procedures-idUSASB0C5NW",
    "ord_in_thread": 0,
    "title": "BRIEF-Abiomed Receives Approval For Expanded FDA Indication For High Risk PCI Procedures",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 14 (Reuters) - Abiomed Inc:\n* ABIOMED RECEIVES APPROVAL FOR EXPANDED FDA INDICATION FOR HIGH RISK PERCUTANEOUS CORONARY INTERVENTION (PCI) PROCEDURES Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-14T21:12:00.000+02:00",
    "crawled": "2018-02-15T20:30:23.004+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "abiomed",
        "inc",
        "abiomed",
        "receives",
        "approval",
        "expanded",
        "fda",
        "indication",
        "high",
        "risk",
        "percutaneous",
        "coronary",
        "intervention",
        "pci",
        "procedure",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}